Attached files

file filename
EX-99.01 - EXHIBIT 99.01 - PALISADE BIO, INC.v433235_ex99-01.htm

  

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): March 4, 2016 (March 3, 2016)

 

 

Neuralstem, Inc.

(Exact name of registrant as specified in Charter)

 

 

Delaware   001-33672   52-2007292

(State or other jurisdiction of

incorporation or organization)

  (Commission File No.)   (IRS Employee Identification No.)

 

20271 Goldenrod Lane, 2 nd Floor, Germantown, Maryland 20876

(Address of Principal Executive Offices)

 

(301) 366-4960

(Issuer Telephone number)

  

 

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  
       
  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  
       
  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
       
           

 

 

 

Item 8.01.Other Events.

 

On March 3, 2016, Neuralstem, Inc. (the “Company”) updated its corporate presentation on its website. A copy of the presentation is attached to this report as Exhibit 99.01. Additionally the presentation is also available on the Company’s website at www.neuralstem.com.

   

 

Item 9.01Financial Statement and Exhibits.

 

         

Exhibit

No.

 

 

  

Description

   
99.01   Corporate Presentation    

 

 

 

 

 

   

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

  

Date: March 4, 2016 Neuralstem, Inc.  
       
       
    /s/ Richard Daly  
    By: Richard Daly  
    Chief Executive Officer  
       

 

  

 

 

 

 

 

INDEX OF EXHIBITS

 

         

Exhibit

No.

 

 

  

Description

   
99.01   Corporate Presentation